Effectiveness of semaglutide in oral vs subcutaneous injectable formulation
A UK realworld data from Association of British Clinical Diabetologists national audit
Presented at EASD 61th Annual Meeting, Vienna, September 2025
K. Su Khin 1 , T. Crabtree 2 , A. Liarakos 1 , W. Ahmad 3 , A. Maliekal 3 , V. Oguntolu 4 , A. Gough 5 , S. Krishnasamy 6 , H. Reid 7 , K. Adamson 7 , G.R. Mudiyanselage 5 , E. Wilmot 8 , I. Idris 9 , R.E.J. Ryder 10
1 Diabetes, Royal Derby Hospital, Derby, UK, 2 Royal Derby Hospital, University Hospitals of Derby and Burton NHS Trust, UK, Derby, UK, 3 Darlington Memorial Hospital, Darlington, UK, 4 Medway Hospital NHS trust, Gilingham, UK, 5 Medway NHS foundation Trust, Gillingham, UK, 6 Walsall Healthcare NHS foundation trust, Walsall, UK, 7 St John's Hospital, Livingston, UK, 8 University Hospitals of Derby and Burton NHS FT, Derby, UK, 9 The University of Nottingham, Derby, UK, 10 City Hospital, Birmingham, UK.
